Skip to content

Clinical trials

Multiple Sclerosis trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Country / region: Brazil Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20092
20101
20111
20121
20132
20172
20183
20192
20203
20212
20222
20232
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting11
Unknown status8
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Novartis Pharmaceuticals6
Genzyme, a Sanofi Company3
Sanofi3
Biogen2
Hospital Israelita Albert Einstein2
Pontificia Universidade Católica do Rio Grande do Sul2
University of Sao Paulo2
Avanir Pharmaceuticals1
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis34
Multiple Sclerosis, Relapsing-Remitting8
Multiple Sclerosis, Chronic Progressive4
Optic Neuritis2
Amyotrophic Lateral Sclerosis1
Anxiety Disorders1
Cerebral Palsy1
Communication Disorders1
Demyelinating Diseases1
Disease Progression1

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.